Gene and Cell Therapy – Webinars and Online Events

Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.

Cell and gene therapies harness the power of cells or genetic material to treat, cure or prevent diseases. These cutting-edge therapeutics have the potential to revolutionize medical treatments, especially for conditions that were previously thought to be incurable, including genetic disorders, cancer and degenerative conditions.

To ensure the safety and efficacy of LNP-based drugs, comprehensive characterization of these sophisticated molecules–the lipids and the genetic cargo–is paramount.

Cell therapies often involve introduction of genetically transformed cells into a patient. Recently there has been renewed interest in non-viral gene modification for this application as an alternative to lentiviral vectors.

In this webinar, our expert speakers will explore the vital role of qPCR and digital PCR in supporting advanced therapy medicinal products, including cell therapies. Discover best practices for assay design, validation parameters and acceptance criteria crucial for ensuring the safety and efficacy of cell therapy programs. Learn how molecular precision can safeguard these innovative therapies and drive breakthroughs in the field.

In this webinar, you will learn about the OGM workflow and how it can be applied to cell and gene therapy R&D, with emphasis on how it can significantly improve the quality, safety and overall risk profile of next-generation therapies.

This one-day online event will feature short talks covering recent innovations in research and technology in the cell and gene therapy domain. Our expert panel of presenters will address key advances across the entire R&D pipeline, from pre-clinical work right through to bioprocessing and manufacturing.

There are hundreds of drug candidates to screen for purity, integrity and stability during early drug development, which can become a considerable bottleneck.

To adequately assess the safety and efficacy of candidate gene therapies, robust bioanalytical technologies must support regulated studies. Hence, many labs now incorporate the latest qPCR and digital PCR (dPCR) methods into their preclinical and clinical development workflows to assure data accuracy and product effectiveness.

Unleash the potential of genetic analysis technologies in gene therapy development. Join this webinar to explore the scientific advancements and breakthroughs made possible by analytical methods. Discover how these technologies overcome challenges, enabling critical product characterization, safety and regulatory compliance.